Miconazole Target (Miconazole Nitrate)

Miconazole belongs to the imidazole class of antifungals. It blocks the fungal enzyme lanosterol 14α‑demethylase, a cytochrome P450 isoform essential for converting lanosterol to ergosterol. Without ergosterol, the fungal cell membrane becomes unstable, leading to increased permeability and cell death, which stops the infection from spreading.

The dosage of Miconazole Target is determined by the prescribing healthcare professional based on the specific infection, its severity, patient age, and the product’s formulation. Patients should follow the prescriber’s instructions or the label directions regarding the amount to apply and the frequency of application.

Safety data for topical miconazole during pregnancy and lactation are limited. Healthcare providers usually weigh the benefits against potential risks. If treatment is necessary, the prescriber may allow limited use, but it is important to discuss any concerns with a qualified medical professional before starting therapy.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the inquiry form. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Miconazole is an imidazole antifungal with a broad spectrum against dermatophytes and Candida species. Compared with allylamine agents such as terbinafine, miconazole offers a similar efficacy for superficial infections but may have a higher incidence of local irritation. Choice of therapy depends on infection type, patient tolerance, and prescriber preference.

Miconazole Target should be stored at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, excessive heat, and direct sunlight. Ensure the container is tightly closed when not in use to maintain product stability.

Miconazole Target is applied topically to the affected skin area. Clean and dry the area before use, then spread a thin layer of the product over the lesion and a small margin of surrounding skin. Follow the prescriber’s frequency recommendations, typically twice daily, and continue treatment for the full course even if symptoms improve.

While most reactions are mild, serious risks include severe allergic responses such as contact dermatitis, urticaria, swelling, or anaphylaxis. If any signs of a systemic allergic reaction appear—such as difficulty breathing, facial swelling, or widespread rash—stop using the product immediately and seek emergency medical care.

Miconazole Target should be avoided by individuals with a known hypersensitivity to miconazole, other imidazole antifungals, or any component of the formulation. It is also contraindicated on extensive broken skin, mucous membranes, or the eyes. Patients with a history of severe skin reactions should consult a healthcare professional before use.